Globally connected AI imaging
Discover how our BioVolume™ globally connected AI imaging and analysis platform is revolutionising the collection of subcutaneous tumour data in pre-clinical oncology research. More than 50% of pre-clinical studies cannot be reproduced, costing the industry $28.8 billion annually. The cost of the drug discovery journey from lab to patient has doubled in the past 10 years, highlighting the commercial challenge of bringing new drugs to market. This presentation shows how science and confidence in drug development can be improved using digital data, AI and machine learning.
Click here to view and download the presentation.